New York State Teachers Retirement System trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 1.8% during the 3rd quarter, Holdings Channel reports. The fund owned 117,892 shares of the company’s stock after selling 2,221 shares during the period. New York State Teachers Retirement System’s holdings in Henry Schein were worth $8,594,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Empirical Finance LLC boosted its holdings in shares of Henry Schein by 3.5% in the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock valued at $360,000 after buying an additional 160 shares in the last quarter. Cromwell Holdings LLC boosted its holdings in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares in the last quarter. Covestor Ltd boosted its holdings in shares of Henry Schein by 12.8% in the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock valued at $114,000 after buying an additional 171 shares in the last quarter. Simplify Asset Management Inc. boosted its holdings in shares of Henry Schein by 5.0% in the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock valued at $237,000 after buying an additional 175 shares in the last quarter. Finally, Sequoia Financial Advisors LLC raised its position in shares of Henry Schein by 3.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock valued at $364,000 after purchasing an additional 176 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on HSIC shares. UBS Group decreased their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. StockNews.com lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Evercore ISI increased their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Robert W. Baird reduced their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $77.50.
Henry Schein Price Performance
Shares of NASDAQ HSIC opened at $70.37 on Monday. The stock has a market capitalization of $8.92 billion, a price-to-earnings ratio of 26.06, a PEG ratio of 2.02 and a beta of 0.87. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63. The firm’s 50 day simple moving average is $70.63 and its 200-day simple moving average is $69.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $3.10 billion for the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business’s revenue was up .0% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. Analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.
Insiders Place Their Bets
In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.14% of the stock is currently owned by company insiders.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- 3 REITs to Buy and Hold for the Long Term
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- The How and Why of Investing in Gold Stocks
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- The 3 Best Blue-Chip Stocks to Buy Now
- Battle of the Retailers: Who Comes Out on Top?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.